ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,567Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 337

$762K Total Retail Price of All Prescriptions

Rank: 25 out of 337

488 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 488 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 488 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,959 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 597 427 1 1
LISINOPRIL 536 360 2 2
OMEPRAZOLE 504 357 3 4
FUROSEMIDE 354 282 4 8
METFORMIN HCL 315 236 5 12
METOPROLOL TARTRATE 288 244 6 6
HYDROCODONE-ACETAMINOPHEN 280 125 S3 7 13
AMLODIPINE BESYLATE 272 228 8 3
WARFARIN SODIUM 246 244 9 11
ATORVASTATIN CALCIUM 244 195 10 7
LEVOTHYROXINE SODIUM 226 184 11 5
TRAZODONE HCL 217 146 12 16
PANTOPRAZOLE SODIUM 190 141 13 36
BISOPROLOL FUMARATE 188 163 14 67
LISINOPRIL-HYDROCHLOROTHIAZIDE 185 145 15 31
TRAMADOL HCL 171 117 16 32
GABAPENTIN 171 101 16 20
ATENOLOL 153 123 18 10
SERTRALINE HCL 140 92 19 18
PROAIR HFA 138 108 20 38
CLOPIDOGREL 131 123 21 42
HYDROCHLOROTHIAZIDE 127 101 22 9
LOSARTAN POTASSIUM 127 123 22 15
DONEPEZIL HCL 122 122 24 22
LOVASTATIN 122 78 24 24
TAMSULOSIN HCL 121 121 26 25
ZOLPIDEM TARTRATE 118 99 27 23
KLOR-CON M20 116 108 28 65
PREDNISONE 109 76 29 40
DILTIAZEM 24HR ER 106 91 30 76
NAMENDA 105 105 31 35
FLUOXETINE HCL 101 82 32 57
LANTUS 95 82 33 49
CITALOPRAM HBR 94 64 34 17
AZITHROMYCIN 93 66 35 51
PRAVASTATIN SODIUM 89 81 36 14
ISOSORBIDE MONONITRATE ER 88 72 37 70
HUMALOG 87 48 38 153
PLAVIX 85 79 39 74
RANITIDINE HCL 84 64 40 30
LYRICA 84 42 40 280
MIRTAZAPINE 82 68 42 27
NAPROXEN 81 32 43 98
SPIRIVA 80 63 44 43
ALLOPURINOL 76 49 45 28
LOSARTAN-HYDROCHLOROTHIAZIDE 76 74 45 60
CIPROFLOXACIN HCL 70 55 47 71
AGGRENOX 68 68 48 174
IBUPROFEN 67 35 49 64
NYSTOP 65 60 50 140
ALPRAZOLAM 64 64 51 78
NEXIUM 64 39 51 56
POLYETHYLENE GLYCOL 3350 64 46 51 47
DIOVAN 63 46 54 26
SYNTHROID 63 63 54 41
CYCLOBENZAPRINE HCL 61 0 R 56 103
OXYCODONE HCL-ACETAMINOPHEN 61 24 S2 56 152
GLIPIZIDE ER 61 48 56 69
ADVAIR DISKUS 59 23 59 44
BYSTOLIC 59 53 59 91
QUETIAPINE FUMARATE 59 24 59 61
BISOPROLOL-HYDROCHLOROTHIAZIDE 59 59 59 95
OXYCODONE HCL 58 0 S2 63 63
FLUTICASONE PROPIONATE 56 36 64 34
NOVOLOG 55 36 65 106
VENLAFAXINE HCL 53 0 66 168
ENALAPRIL MALEATE 53 42 66 37
CYMBALTA 53 20 66 59
GLYBURIDE-METFORMIN HCL 52 48 R 69 99
DILTIAZEM ER 50 36 70 169
QUINAPRIL HCL 50 38 70 50
POTASSIUM CHLORIDE 50 48 70 62
LIDODERM 50 30 70 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.